G C Kabat1, W Y-Y Wu2,3, J W Bea4, C Chen5, L Qi6, M L Stefanick7, R T Chlebowski8, D S Lane9, J Wactawski-Wende10, S Wassertheil-Smoller1, T E Rohan1. 1. Department of Epidemiology and Population Health, Albert Einstein College of Medicine, Bronx, NY, USA. 2. Department of Radiation Sciences Oncology, Umeå University, Umeå, Sweden. 3. Graduate School of Epidemiology and Department of Preventive Medicine, College of Public Health, National Taiwan University, Taipei, Taiwan. 4. Department of Medicine, Arizona Cancer Center, Tucson, AZ, USA. 5. Department of Epidemiology, School of Public Health, Fred Hutchinson Cancer Research Center, Seattle, WA, USA. 6. Department of Public Health Sciences, School of Medicine, University of California at Davis, Davis, CA, USA. 7. Stefanick Department of Medicine, Stanford University, Stanford, CA, USA. 8. Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center, Torrance, CA, USA. 9. Department of Preventive Medicine, School of Medicine, Stony Brook University, Stony Brook, NY, USA. 10. Department of Social and Preventive Medicine, School of Public Health and Health Professions, University at Buffalo, Buffalo, NY, USA.
Abstract
OBJECTIVE: The possibility that a subset of persons who are obese may be metabolically healthy-referred to as the 'metabolically healthy obese' (MHO) phenotype-has attracted attention recently. However, few studies have followed individuals with MHO or other obesity phenotypes over time to assess change in their metabolic profiles. The aim of the present study was to examine transitions over a 6-year period among different states defined simultaneously by body mass index (BMI) and the presence/absence of the metabolic syndrome (MetS). METHODS: We used repeated measurements available for a subcohort of participants enrolled in the Women's Health Initiative (N=3512) and followed for an average of 6 years to examine the frequency of different metabolic obesity phenotypes at baseline, the 6-year transition probabilities to other states and predictors of the risk of different transitions. Six phenotypes were defined by cross-tabulating BMI (18.5-<25.0, 25.0-<30.0, ⩾30.0 kg m-2) by MetS (yes, no). A continuous-time Markov model was used to estimate 6-year transition probabilities from one state to another. RESULTS: Over the 6 years of follow-up, one-third of women with the healthy obese phenotype transitioned to the metabolically unhealthy obese (MUO) phenotype. Overall, there was a marked tendency toward increased metabolic deterioration with increasing BMI and toward metabolic improvement with lower BMI. Among MHO women, the 6-year probability of becoming MUO was 34%, whereas among unhealthy normal-weight women, the probability of 'regressing' to the metabolically healthy normal-weight phenotype was 52%. CONCLUSIONS: The present study demonstrated substantial change in metabolic obesity phenotypes over a 6-year period. There was a marked tendency toward metabolic deterioration with greater BMI and toward metabolic improvement with lower BMI.
OBJECTIVE: The possibility that a subset of persons who are obese may be metabolically healthy-referred to as the 'metabolically healthy obese' (MHO) phenotype-has attracted attention recently. However, few studies have followed individuals with MHO or other obesity phenotypes over time to assess change in their metabolic profiles. The aim of the present study was to examine transitions over a 6-year period among different states defined simultaneously by body mass index (BMI) and the presence/absence of the metabolic syndrome (MetS). METHODS: We used repeated measurements available for a subcohort of participants enrolled in the Women's Health Initiative (N=3512) and followed for an average of 6 years to examine the frequency of different metabolic obesity phenotypes at baseline, the 6-year transition probabilities to other states and predictors of the risk of different transitions. Six phenotypes were defined by cross-tabulating BMI (18.5-<25.0, 25.0-<30.0, ⩾30.0 kg m-2) by MetS (yes, no). A continuous-time Markov model was used to estimate 6-year transition probabilities from one state to another. RESULTS: Over the 6 years of follow-up, one-third of women with the healthy obese phenotype transitioned to the metabolically unhealthy obese (MUO) phenotype. Overall, there was a marked tendency toward increased metabolic deterioration with increasing BMI and toward metabolic improvement with lower BMI. Among MHO women, the 6-year probability of becoming MUO was 34%, whereas among unhealthy normal-weight women, the probability of 'regressing' to the metabolically healthy normal-weight phenotype was 52%. CONCLUSIONS: The present study demonstrated substantial change in metabolic obesity phenotypes over a 6-year period. There was a marked tendency toward metabolic deterioration with greater BMI and toward metabolic improvement with lower BMI.
Authors: B V Howard; L Adams-Campbell; C Allen; H Black; M Passaro; R J Rodabough; B L Rodriguez; M Safford; V J Stevens; L E Wagenknecht Journal: Int J Obes Relat Metab Disord Date: 2004-08
Authors: Anne McTiernan; Charles Kooperberg; Emily White; Sara Wilcox; Ralph Coates; Lucile L Adams-Campbell; Nancy Woods; Judith Ockene Journal: JAMA Date: 2003-09-10 Impact factor: 56.272
Authors: Antony D Karelis; David H St-Pierre; Florence Conus; Remi Rabasa-Lhoret; Eric T Poehlman Journal: J Clin Endocrinol Metab Date: 2004-06 Impact factor: 5.958
Authors: Joshua A Bell; Mark Hamer; Séverine Sabia; Archana Singh-Manoux; G David Batty; Mika Kivimaki Journal: J Am Coll Cardiol Date: 2015-01-06 Impact factor: 24.094
Authors: Luca A Lotta; Ali Abbasi; Stephen J Sharp; Anna-Stina Sahlqvist; Dawn Waterworth; Julia M Brosnan; Robert A Scott; Claudia Langenberg; Nicholas J Wareham Journal: Diabetes Care Date: 2015-11 Impact factor: 19.112
Authors: Hsin-Yun Chang; Jer-Hao Chang; Yin-Fan Chang; Chih-Hsing Wu; Yi-Ching Yang Journal: Int J Environ Res Public Health Date: 2022-07-04 Impact factor: 4.614
Authors: Justin B Echouffo-Tcheugui; Meghan I Short; Vanessa Xanthakis; Patrick Field; Todd R Sponholtz; Martin G Larson; Ramachandran S Vasan Journal: J Clin Endocrinol Metab Date: 2019-03-01 Impact factor: 5.958
Authors: Alice Tang; Adelle C F Coster; Katherine T Tonks; Leonie K Heilbronn; Nicholas Pocock; Louise Purtell; Matthew Govendir; Jackson Blythe; Jialiang Zhang; Aimin Xu; Donald J Chisholm; Nathan A Johnson; Jerry R Greenfield; Dorit Samocha-Bonet Journal: J Clin Med Date: 2019-05-08 Impact factor: 4.241
Authors: Leonardo Victor Galvão-Moreira; Anna Cyntia Brandão Nascimento; Izabella Mikaella Souza Campos D'Albuquerque; Marcus Antonio Silva Sousa; Haissa Oliveira Brito; Maria do Desterro Soares Brandão Nascimento; Maria Bethânia da Costa Chein; Luciane Maria Oliveira Brito Journal: PLoS One Date: 2019-09-11 Impact factor: 3.240